Why the study?
Does RNH-6270 inhibit the growth of vascular smooth muscle cells from spontaneously hypertensive rats compared to an ACE inhibitor?
Does RNH-6270 inhibit the growth of vascular smooth muscle cells from spontaneously hypertensive rats compared to an ACE inhibitor?
RNH-6270, a novel AT1 receptor antagonist, demonstrates potent anti-proliferative effects on vascular smooth muscle cells from spontaneously hypertensive rats, an effect not seen with the ACE inhibitor temocapril.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for AT1 antagonism in vascular remodeling; leaves open translation to human disease.
The current study was undertaken to evaluate the anti-proliferative effect of a novel angiotensin II type 1 (AT1) receptor antagonist, RNH-6270, on exaggerated growth of vascular smooth muscle cells (VSMC) from spontaneously hypertensive rats (SHR), in comparison with the effects of an angiotensin-converting enzyme (ACE) inhibitor. RNH-6270 and temocapril significantly inhibited basal DNA synthesis in VSMCs from SHRs in a dose-dependent manner, but not in cells from Wistar-Kyoto (WKY) rats. SHR-derived VSMC showed a hyperresponse of DNA synthesis to serum and angiotensin II compared with that of WKY rats-derived VSMC. RNH-6270 did not affect serum-stimulated DNA synthesis in VSMCs from both rat strains. RNH-6270 abolished angiotensin II-stimulated DNA synthesis in VSMC from both rat strains. RNH-6270 significantly inhibited proliferation of VSMC from both rat strains, but the ACE inhibitor temocapril did not exert such an effect. RNH-6270 decreased the specific binding of angiotensin II to VSMC in a competitive manner for angiotensin II receptors in both rat strains. RNH-6270 and temocapril significantly decreased the expression of growth factor mRNAs and proteins in VSMC from SHR, but not in cells from WKY rats. These results suggest that RNH-6270 is a potent AT1 receptor antagonist and has anti-proliferative effects on VSMCs from SHR, which was not seen with an ACE inhibitor. The growth inhibitory effect of RNH-6270 may be associated with the inhibition of growth factors via antagonism to AT1 receptors.
No takes yet. Share an insight, caveat, or question.
Teng et al. (2002) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: